Cadwalader allows sharing content.
Email to a friend or colleague:
From
To
Subject
Email Cadwalader is pleased to have advised Acorda Therapeutics, Inc., a leading biotechnology company, on its execution of a merger agreement to acquire Civitas Therapeutics, Inc., a privately-held biopharmaceutical company, for $525 million in an all cash transaction. https://www.cadwalader.com/news/news-release/cadwalader-advises-acorda-therapeutics-on-merger-agreement-to-acquire-civitas-therapeutics